Validation of Drug Resistance in Pneumonia (DRIP) Score as Empirical Antibiotic Failure Predictor in Community-Acquired Pneumonia Patients in Cipto Mangunkusumo Hospital

Authors

  • Rohayat Bilmahdi Simanjuntak Division of Respirology and Critical Care, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Khie Chen Lie Division of Tropical Medicine and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Cleopas Martin Rumende Division of Respirology and Critical Care, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Murdani Abdullah Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Hamzah Shatri Division of Psychosomatic, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Soekamto Koesnoe Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Leonard Nainggolan Division of Tropical Medicine and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Aulia Rizka Division of Geriatrics, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Keywords:

DRIP score, antibiotics failure, Drug-Resistant Pathogens, Community-Acquired Pneumonia

Abstract

Background: The incidence of CAP due to Drug-Resistant Pathogen (DRP) requires broad-spectrum antibiotic therapy, Drugs Resistance in Pneumonia (DRIP) score can predict these cases. The use of the DRIP score can prevent antibiotic failure and long hospitalization, but validation is needed so that the DRIP score can be used according to the local community at Cipto Mangunkusumo National Central Public Hospital. Methods: This research is a retrospective cohort study in CAP patients who were hospitalized during the period January 2019 to June 2020. Data were taken from medical records. Failure of empiric antibiotics occurs when one of these criteria is found: patient mortality, ICU transfer, and escalation of antibiotics as well as length of stay. Results: 480 patients met the criteria. There were 331 patients (69%) with a DRIP score of <4 and 149 patients (31%) with a DRIP score of≥4. A total of 283 patients (59%) of antibiotic failures were detailed in 174 patients with a DRIP score <4 and 109 patients DRIP score ≥4. DRIP calibration using the Hosmer-Lemeshow test obtained p-value= 0.667 (p>0.05). AUC observations on the ROC curve obtained 0.651 (95% CI; 0.601-0.700). Conclusion: The DRIP score has low accuracy performance and calibration value in predicting empirical antibiotic failure and poor discriminatory value.

References

Rider AC, Frazee BW. Community Acquired Pneumonia. Emerg Med Clin Am. 2018;36:665-83.

Rumende CM, Chen LK, Karuniawan A. Hubungan antara ketepatan pemberian antibiotik berdasarkan alur gyssens dengan perbaikan klinis pasien pada pneumonia komunitas. J Penyakit Dalam Indones. 2019;6(2):71.

Rothberg MB. Community-acquired pneumonia. Ann Intern Med. 2022;175(4):ITC49-ITC64.

Lardo S, Chen LK, Santoso WD, Rumende CM. Hubungan kualitas penggunaan antibiotik menggunakan alur gyssens dengan keberhasilan pengobatan pada sepsis MDR gram negatif di rumah sakit tersier. J Penyakit Dalam Indones. 2021;7(4):221.

Cao B, Huang Y, She DY. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin Respir J. 2018;12(4):1320-60.

Fadrian F, Chen K, Kumalawati J, Rumende CM, Shatri H, Nelwan EJ. The validation of drug resistance in pneumonia (DRIP) score in predicting infections due to drug-resistant pathogens in community-acquired pneumonia at Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Acta Med Indones. 2021;53(4):416-22.

Webb BJ, Dascomb K, Stenehjem E, Dean N. Predicting risk of drug-resistant organisms in pneumonia: Moving beyond the HCAP model. Respir Med. 2015;109(1):1-10.

Oliver MB, Fong K, Certain L, Spivak ES, Timbrook TT. Validation of a community-acquired pneumonia score to improve empiric antibiotic selection at an academic medical center. Antimicrob Agents Chemother. 2021;65(2):1-7.

Almirall J, Serra-Prat M, Bolíbar I, Balasso V. Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies. Respiration. 2017;94(3):299-311.

Webb BJ, Sorensen J, Mecham I. Antibiotic use and outcomes after implementation of the drug resistance in pneumonia score in ED patients with community-onset pneumonia. Chest. 2019;156(5):843-51.

Garau J, Baquero F, Pérez-Trallero E. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect. 2008;14(4):322-9.

Downloads

Published

2024-04-01

How to Cite

Simanjuntak, R. B., Lie, K. C., Rumende, C. M., Abdullah, M., Shatri, H., Koesnoe, S., Nainggolan, L., & Rizka, A. (2024). Validation of Drug Resistance in Pneumonia (DRIP) Score as Empirical Antibiotic Failure Predictor in Community-Acquired Pneumonia Patients in Cipto Mangunkusumo Hospital. Acta Medica Indonesiana, 56(1), 55. Retrieved from https://www.actamedindones.org/index.php/ijim/article/view/2342

Issue

Vol. 56 No. 1 (2024): Acta Medica Indonesiana

Section

ORIGINAL ARTICLE

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.